↓ Skip to main content

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis

Overview of attention for article published in HEPAC Health Economics in Prevention and Care, May 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
Published in
HEPAC Health Economics in Prevention and Care, May 2014
DOI 10.1007/s10198-014-0593-5
Pubmed ID
Authors

Petra Baji, Márta Péntek, Sándor Szántó, Pál Géher, László Gulácsi, Orsolya Balogh, Valentin Brodszky

Abstract

To compare the efficacy and safety of infliximab-biosimilar with other biological drugs for the treatment of active ankylosing spondylitis (AS).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 3%
Germany 1 <1%
Brazil 1 <1%
Unknown 96 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 19%
Researcher 17 17%
Other 14 14%
Student > Bachelor 10 10%
Student > Ph. D. Student 9 9%
Other 17 17%
Unknown 15 15%
Readers by discipline Count As %
Medicine and Dentistry 42 42%
Agricultural and Biological Sciences 12 12%
Pharmacology, Toxicology and Pharmaceutical Science 11 11%
Biochemistry, Genetics and Molecular Biology 5 5%
Nursing and Health Professions 2 2%
Other 12 12%
Unknown 17 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2014.
All research outputs
#22,759,802
of 25,374,647 outputs
Outputs from HEPAC Health Economics in Prevention and Care
#1,211
of 1,303 outputs
Outputs of similar age
#209,211
of 241,958 outputs
Outputs of similar age from HEPAC Health Economics in Prevention and Care
#30
of 38 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,303 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,958 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.